Colorectal and Hirschsprung Center for Children, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, USA.
J Pediatr Surg. 2019 Nov;54(11):2311-2317. doi: 10.1016/j.jpedsurg.2019.04.009. Epub 2019 Apr 24.
At the severe end of the idiopathic constipation spectrum exist patients with chronic idiopathic constipation associated with an enormous megarectosigmoid, among whom few require surgery. We performed transanal proximal rectosigmoidectomy, involving preservation of a 5 cm rectal reservoir, to ameliorate inconsistent and unpredictable outcomes and fecal incontinence occurring in some patients operated on with other techniques.
We retrospectively observed patients with chronic idiopathic constipation with megarectosigmoid who underwent transanal proximal rectosigmoidectomy during July 2017-May 2018. We analyzed sex, age, operation indication, complications, functional outcome, and time of follow-up. We statistically compared the dosage of laxative before and after the procedure.
Thirteen patients were included in the study. Median age during surgery was 8 years. In 9 cases, the indication for surgery was chronic intake of a daily high dose of Senna with failed weaning trials, and 4 had persistent fecal impaction with laxative-intolerance and refusal of rectal enemas. No intra/postoperative complications occurred. Currently, all 13 patients have daily voluntary bowel movements and no fecal accidents. Laxative dosage was significantly reduced (p = 0.007). Follow-up ranged 6-16 months.
Preliminary results suggest transanal proximal rectosigmoidectomy as an adequate alternative for patients requiring surgery for chronic idiopathic constipation with megarectosigmoid.
Clinical research.
Level III.
在特发性便秘的严重阶段,存在伴有巨大巨直肠的慢性特发性便秘患者,其中很少有需要手术的。我们进行了经肛门近端直肠乙状结肠切除术,保留 5cm 的直肠储袋,以改善一些采用其他技术手术的患者出现的结果不一致和不可预测以及大便失禁的情况。
我们回顾性观察了 2017 年 7 月至 2018 年 5 月期间接受经肛门近端直肠乙状结肠切除术的慢性特发性便秘伴巨直肠患者。我们分析了性别、年龄、手术指征、并发症、功能结果和随访时间。我们对手术前后泻药的剂量进行了统计学比较。
本研究共纳入 13 例患者。手术时的中位年龄为 8 岁。9 例患者的手术指征为慢性服用大剂量番泻叶(Senna),且无法逐渐停药,4 例患者因不能耐受泻药且拒绝直肠灌肠而持续发生粪便嵌塞。无围手术期并发症。目前,所有 13 例患者均有每日自愿排便,无粪便意外。泻药剂量显著减少(p=0.007)。随访时间为 6-16 个月。
初步结果表明,对于需要手术治疗的慢性特发性便秘伴巨大巨直肠的患者,经肛门近端直肠乙状结肠切除术是一种合适的替代方法。
临床研究
三级